Pinnacle Associates’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Pinnacle Associates’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,650	Closed	-$326K	–	683
2020 Q2	$326K	Sell	1,650 -3,542	-68%	-$734K	0.01%	547
2020 Q1	$1.02M	Buy	5,192 +7	+0.1%	+$1.51K	0.03%	335
2019 Q4	$1.07M	Buy	5,185 +25	+0.5%	+$4.62K	0.02%	393
2019 Q3	$788K	Buy	5,160 +676	+15%	+$111K	0.02%	452
2019 Q2	$578K	Buy	4,484 +2,525	+129%	+$300K	0.01%	510
2019 Q1	$231K	Buy	+1,959	New	+$198K	0.01%	646

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Pinnacle Associates's LKFT Position: Q3 2020 in Review

Pinnacle Associates sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 1,650 shares — an estimated $326K sold.

Pinnacle Associates first reported a position in LKFT in Q1 2019 and held it in 6 quarters. The position peaked at $1.07M in Q4 2019. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

Pinnacle Associates reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Pinnacle Associates sold 1,650 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $326K.
Pinnacle Associates first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2019 and held it in 6 quarters.
Pinnacle Associates's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.07M in Q4 2019.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Pinnacle Associates's 13F filing for Q3 2020, filed 23 Oct 2020.